ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J D B who wrote (378)	12/1/1998 7:53:00 AM
From: Dr. John M. de Castro	Read Replies (2) of 4474

Does anyone have an opinion as to how this might affect Ariad? Will this change the Genomics center deal with Hoechst? Does Rhône-Poulenc have a comparable unit to the Genomics center? this could be a plus for Ariad if there is no redundancy, but, it could be a big minus if there is. "Germany's Hoechst and France's Rhône-Poulenc confirmed Tuesday they will merge their pharmaceuticals and agricultural businesses" cnnfn.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next